Literature DB >> 30827757

Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression.

S J Iwabuchi1, D P Auer1, S T Lankappa2, L Palaniyappan3.   

Abstract

Repetitive transcranial magnetic stimulation (rTMS) has become a popular treatment option for treatment-resistant depression (TRD). However, suboptimal response rates highlight the need for improved efficacy through optimisation of treatment protocol and patient selection. We investigate whether the limbic salience network and its connectivity with prefrontal stimulation sites predict immediate and longer-term responsiveness to rTMS. Twenty-seven patients with TRD were randomly allocated to receive 16 sessions of either conventional rTMS or intermittent theta-burst (iTBS) over 4 weeks; delivered using connectivity profiling and neuronavigation to target person-specific dorsolateral prefrontal cortex (DLPFC). At baseline and 3-month follow-up, patients underwent clinical assessment and scanning session, and 1-month clinical follow-up. Resting-state fMRI data were entered into seed-based functional and effective connectivity analyses between right anterior insula (rAI) and DLPFC target, and independent components analysis to extract resting-state networks. Cerebral blood flow (CBF) was also assessed in the rAI. All brain measures were compared between baseline and follow-up, and related to treatment response at 1- and 3-months. Baseline fronto-insular effective connectivity and salience network connectivity were significantly positively correlated, while baseline rAI CBF was negatively correlated, with early (1-month) response to rTMS treatment but not sustained response (3-months), suggesting persistence of therapeutic response is not associated with baseline features. Connectivity or CBF measures did not change between the two time points. We demonstrate that fronto-insular and salience-network interactions can predict early response to rTMS in TRD, suggesting that these network nodes may be key regions toward developing rTMS response biomarkers.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Depression; Effective connectivity; Response prediction; Salience network; rTMS

Year:  2019        PMID: 30827757     DOI: 10.1016/j.euroneuro.2019.02.012

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND).

Authors:  Richard Morriss; Lucy Webster; Mohamed Abdelghani; Dorothee P Auer; Shaun Barber; Peter Bates; Andrew Blamire; Paul M Briley; Cassandra Brookes; Sarina Iwabuchi; Marilyn James; Catherine Kaylor-Hughes; Sudheer Lankappa; Peter Liddle; Hamish McAllister-Williams; Alex O'Neill-Kerr; Stefan Pszczolkowski Parraguez; Ana Suazo Di Paola; Louise Thomson; Yvette Walters
Journal:  BMJ Open       Date:  2020-07-07       Impact factor: 2.692

Review 2.  Repetitive Transcranial Magnetic Stimulation for the Treatment of Resistant Depression: A Scoping Review.

Authors:  Medard Kofi Adu; Reham Shalaby; Pierre Chue; Vincent I O Agyapong
Journal:  Behav Sci (Basel)       Date:  2022-06-17

Review 3.  Resting State Functional Connectivity Biomarkers of Treatment Response in Mood Disorders: A Review.

Authors:  Joseph J Taylor; Hatice Guncu Kurt; Amit Anand
Journal:  Front Psychiatry       Date:  2021-03-26       Impact factor: 4.157

Review 4.  Causal Inferences in Repetitive Transcranial Magnetic Stimulation Research: Challenges and Perspectives.

Authors:  Justyna Hobot; Michał Klincewicz; Kristian Sandberg; Michał Wierzchoń
Journal:  Front Hum Neurosci       Date:  2021-01-14       Impact factor: 3.169

5.  The functional and structural associations of aberrant microglial activity in major depressive disorder.

Authors:  Jasmine D Cakmak; Linshan Liu; Stefan E Poirier; Betsy Schaefer; Raju Poolacherla; Amer M Burhan; Priyadharshini Sabesan; Keith St Lawrence; Jean Théberge; Justin W Hicks; Elizabeth Finger; Lena Palaniyappan; Udunna C Anazodo
Journal:  J Psychiatry Neurosci       Date:  2022-06-02       Impact factor: 5.699

6.  A pilot study exploring the effect of repetitive transcranial magnetic stimulation (rTMS) treatment on cerebral blood flow and its relation to clinical outcomes in severe enduring anorexia nervosa.

Authors:  Bethan Dalton; Erica Maloney; Samantha J Rennalls; Savani Bartholdy; Maria Kekic; Jessica McClelland; Iain C Campbell; Ulrike Schmidt; Owen G O'Daly
Journal:  J Eat Disord       Date:  2021-07-09

7.  Precision non-implantable neuromodulation therapies: a perspective for the depressed brain.

Authors:  Lucas Borrione; Helena Bellini; Lais Boralli Razza; Ana G Avila; Chris Baeken; Anna-Katharine Brem; Geraldo Busatto; Andre F Carvalho; Adam Chekroud; Zafiris J Daskalakis; Zhi-De Deng; Jonathan Downar; Wagner Gattaz; Colleen Loo; Paulo A Lotufo; Maria da Graça M Martin; Shawn M McClintock; Jacinta O'Shea; Frank Padberg; Ives C Passos; Giovanni A Salum; Marie-Anne Vanderhasselt; Renerio Fraguas; Isabela Benseñor; Leandro Valiengo; Andre R Brunoni
Journal:  Braz J Psychiatry       Date:  2020-03-16       Impact factor: 2.697

8.  Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled Trial.

Authors:  Stefan Pszczolkowski; William J Cottam; Paul M Briley; Sarina J Iwabuchi; Catherine Kaylor-Hughes; Abdulrhman Shalabi; Ben Babourina-Brooks; Adam Berrington; Shaun Barber; Ana Suazo Di Paola; Andrew Blamire; R Hamish McAllister-Williams; Jehill Parikh; Mohamed Abdelghani; Lars Matthäus; Ralf Hauffe; Peter Liddle; Dorothee P Auer; Richard Morriss
Journal:  JMIR Res Protoc       Date:  2022-01-20

9.  Proof of concept study to develop a novel connectivity-based electric-field modelling approach for individualized targeting of transcranial magnetic stimulation treatment.

Authors:  Nicholas L Balderston; Joanne C Beer; Darsol Seok; Walid Makhoul; Zhi-De Deng; Tommaso Girelli; Marta Teferi; Nathan Smyk; Marc Jaskir; Desmond J Oathes; Yvette I Sheline
Journal:  Neuropsychopharmacology       Date:  2021-07-28       Impact factor: 7.853

10.  Treatment of major depressive disorder with bilateral theta burst stimulation: study protocol for a randomized, double-blind, placebo-controlled multicenter trial (TBS-D).

Authors:  Christian Plewnia; Bettina Brendel; Tobias Schwippel; Vanessa Nieratschker; Thomas Ethofer; Thomas Kammer; Frank Padberg; Peter Martus; Andreas J Fallgatter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-06-19       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.